2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
glyBURIDE (Diabeta, Glynase, Micronase)
Criteria 1: Potentially inappropriate medication use in older adults. (Table 2)
Comments
aka glibenclamide
Drug(s)
sulfonylureas (all, including short- and longer-acting)
Rationale
Sulfonylureas have a higher risk of cardiovascular events, all-cause mortality, and hypoglycemia than alternative agents. Sulfonylureas may increase the risk of cardiovascular death and ischemic stroke. Among sulfonylureas, long-acting agents (e.g., glyBURIDE, glimepiride) confer a higher risk of prolonged hypoglycemia than short-acting agents (e.g., glipiZIDE).
Recommendation
Avoid sulfonylureas as first- or second-line monotherapy or add-on therapy unless there are substantial barriers to the use of safer and more effective agents. If a sulfonylurea is used, choose short-acting agents (e.g., glipiZIDE) over long-acting agents (e.g., glyBURIDE, glimepiride).
Quality of evidence: Hypoglycemia: High CV events and all-cause mortality: Moderate CV death and ischemic stroke: Low, Strength of Recommendation: Strong
Among sulfonylureas, long-acting agents (e.g., glyBURIDE, glimepiride) confer a higher risk of prolonged hypoglycemia than short-acting agents (e.g., glipiZIDE).
If a sulfonylurea is used, choose short-acting agents (e.g., glipiZIDE) over long-acting agents (e.g., glyBURIDE, glimepiride).
CV events and all-cause mortality: Moderate
CV death and ischemic stroke: Low, Strength of Recommendation: Strong